PRKN and Parkinson disease: miR-34b and miR-34c were found to be downregulated in PD patients and specifically in the amygdala, SNpc, frontal cortex and cerebellum, coupled with a significant decrease in the concentrations of PARKIN and DJ-1 proteins [95] (see Section 4).